Deadline on April 25th coming up in Lawsuit for Investors in Catalent, Inc. (NYSE: CTLT)

A deadline is coming up on April 25, 2023 in the lawsuit filed for certain investors of Catalent, Inc. (NYSE: CTLT) over alleged securities laws violations by Catalent, Inc.

Investors who purchased shares of Catalent, Inc. (NYSE: CTLT) have certain options and there are strict and short deadlines running. Deadline: April 25, 2023. NYSE: CTLT stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the the U.S. District Court for the District of New Jersey the plaintiff alleges on behalf of purchasers of Catalent, Inc. (NYSE: CTLT) common shares between August 30, 2021 and October 31, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between August 30, 2021 and October 31, 2022, statements made by the defendants were materially false and misleading when made because they misrepresented or failed to disclose the following adverse facts, which were known to Defendants or recklessly disregarded by them: (a) Catalent materially overstated its revenue and earnings by prematurely recognizing revenue in violation of U.S. Generally Accepted Accounting Principles ("GAAP"); (b) Catalent had material weaknesses in its internal control over financial reporting related to revenue recognition; (c) Catalent falsely represented demand for its products while it knowingly sold more product to its direct customers than could be sold to healthcare providers and end consumers; (d) Catalent disregarded regulatory rules at key production facilities in order to rapidly produce excess inventory that was used to pad the Company's financial results through premature revenue recognition in violation of GAAP and/or stuffing its direct customers with this excess inventory; and (e) as a result of the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company's financial performance, outlook, and regulatory compliance between August 30, 2021 and October 31, 2022.

Those who purchased shares of Catalent, Inc. (NYSE: CTLT) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.